Radiation-attenuated (RA) schistosomes penetrate the host via the skin where they stimulate intense in¯ammatory reactions and the release of pro-in¯ammatory IL-12, important for T h 1-type immune responses which are partially host protective. However, RA larvae also induce the secretion of regulatory IL-10. We now show that following vaccination of IL-12p40 ±/± mice, abundant IL-10 was produced by in vitro cultured skin biopsies between days 4 and 14, corresponding to the down-regulation of MHC II expression by cells in the dermis and cells that emigrate from the skin. In IL-10 ±/± mice, in¯ammation of the vaccination site was increased with larger numbers of IL-12p40 + , MHC II + and CD86 + cells in the dermal exudate, and was associated with elevated levels of skin-derived IL-12p40 and IL-1b. These changes in IL-10 ±/± mice were also re¯ected by an increased number of cells in the skin-draining lymph nodes (sdLN) and greater levels of lymphocyte proliferation. Moreover, such mice had increased numbers of CD4 + sdLN cells that were CD25 + , CD28 + or CD152 + and accessory cells that were CD40 + or MHC II + . Finally, the secretion of IFN-g (and IL-12p40) by in vitro cultured sdLN cells was substantially raised in IL-10 ±/± mice, but much reduced in IL-12p40 ±/± mice, resulting in the development of highly polarized T h 1 and T h 2 cytokine pro®les in the two groups of mice respectively. We conclude that IL-10 has an important role early in the regulation of IL-12-mediated priming of acquired immune responses, and effectively contains excessive dermal in¯ammation and prevents the development of highly polarized T h 1-type responses.
Introduction
The skin is an important organ of the innate immune system, forming an initial line of host defence against infectious pathogens. Immune events in the skin are also likely to be critical in guiding the subsequent priming of adaptive immune responses, particularly in the skin-draining lymph nodes (sdLN), which can confer protective immunity to re-infection. In this context, schistosomes are parasitic helminths that infect mammalian hosts via the skin. Free-swimming cercariae in contaminated water make contact with the skin and burrow through the different layers aided by an array of proteases (1) . Following maturation, schistosomes cause a serious debilitating disease, which affects >500 million people worldwide, and although drug-treatment can be effective, there is a pressing need to develop an ef®cient vaccine.
In the murine model of infection, normal parasites are not thought to induce signi®cant levels of immunologically mediated protection against challenge infection (2, 3) . They are also inef®cient stimulators of innate immune responses in the skin (4) , and acquired immune responses in the sdLN (5) and lungs (6) . In contrast, cercariae attenuated with optimum doses of irradiation consistently induce CD4 + -dependent protective immunity of between 60 and 70% (7, 8) . Acquired immune responses to radiation-attenuated (RA) larvae have been well characterized, demonstrating a strong bias towards T h 1-type, IFN-g-mediated protection (5, 9) , although a role for antibodies is also evident (10±12).
Priming of an ef®cient acquired immune response is dependent upon the generation of a polarized T h 1-type immune response in the sdLN within the ®rst 7±14 days after vaccination (5, 13) , followed by recruitment of these cells to the lungs (14) . However, it is less clear what immune-related events occur in the skin in the ®rst 2 weeks which will contribute towards immune priming in the sdLN. One key feature of RA larvae is that they are much slower to migrate through the skin, thereby extending the period over which they can present antigens to accessory cells of the innate immune system (4, 15, 16) . We recently reported that RA larvae were ef®cient stimulators of various cytokines and chemokines in the skin immediately after vaccination, leading to a strong cellular in¯ammatory response (4) . Chief amongst the cytokines was sustained IL-12p40 induced by RA, but not normal, larvae. IL-12 is a highly potent cytokine able to stimulate NK and T h 1 cells to produce IFN-g (17) , but it also activates potential antigen-presenting cells (APC) such as macrophages and dendritic cells (DC) (18) . Indeed, IL-12 has previously been shown to be important in the development of T h 1-mediated immunity (19) , since vaccinated IL-12p40 ±/± mice have substantially reduced levels of protection against Schistosoma mansoni (~30±40%) that can be restored by intradermal administration of recombinant IL-12 (20) . Nevertheless, we also report that signi®cant quantities of immunoregulatory IL-10 are produced in the skin in response RA larvae (4) . This cytokine is likely to have a major role in down-regulating immune responses in the skin and the sdLN by acting on those accessory cells that conventionally secrete IL-12 (21) . Indeed, in the absence of IL-10, mice exposed to two doses of RA larvae develop a more polarized T h 1-type cytokine pro®le and exhibit high levels of protective immunity of >90% (10) .
In light of the observation that both IL-12 and IL-10 are produced in the skin soon after exposure to RA schistosome larvae, we wished to examine their relative roles during the development of in¯ammatory responses in the skin and the priming of T h cells in the sdLN. We report here that IL-12 and IL-10 act as antagonistics regulating cytokine production in the skin and the expression of MHC II by skin-derived accessory cells. This in turn affects the ef®ciency of immune priming in the sdLN where the absence of IL-10 leads to increased co-stimulatory molecule expression and the enhanced production of T h 1-associated cytokines. The early expression of IL-10 following exposure to the RA schistosome vaccine has important implications in the design of vaccination strategies against different pathogens where a strong T h 1 response is required, but also where excessive in¯amma-tion needs to be controlled.
Methods

Parasite and host
Infective cercariae of S. mansoni were attenuated with 20-krad irradiation ( 60 Co source), and then used to vaccinate groups of anaesthetized female IL-12p40 ±/± (22) and IL-10 ±/± mice (23) (Taconic Farms, Rockville, MD) alongside wild-type C57BL/6 strain cohorts via each pinna as described previously (4, 12) .
Sampling regime
At various time points (days 0, 1, 2, 4, 8 and 14) postvaccination (p.v.), groups of mice (providing 4±6 pinnae) were sacri®ced and the extent of in¯ammation at the exposure site determined by measurement of the pinnae thickness using a dial gauge micrometer (Mitutoyo, Kawasaki, Japan). The pinnae and the auricular draining sdLN were then removed and prepared for histology, culture in vitro or analysis of surface marker and co-stimulatory molecule expression bȳ ow cytometry.
Histology
Pinnae were ®xed in 10% neutral buffered formalin (Sigma, Poole, UK), wax-embedded, sectioned at 6 mm and stained with H & E (EHL, Warrington, UK). For immunohistochemistry, 12-mm cryosections were ®xed in 3.7% paraformaldehyde in PBS for 20 min, washed and air dried. Sections were blocked ®rst with 3% BSA, and then with 1% H 2 O 2 in PBS for 15 min and biotin blocking kit (Vector, Peterborough, UK). Sections were then incubated with biotinylated anti-MHC II antibody (B21.2, Ia b,d ; Caltag-MedSystems, Towcester, UK) for 30 min at room temperature, followed by Vectastain Elite ABC peroxidase reagent combined with Vector VIP enzyme substrate and counterstained with methyl green (Vector).
Preparation of pinnae and sdLN cells for in vitro culture and ow cytometry Pinnae were cultured in vitro as described previously (12) . Brie¯y, each pinna was split and the two faces¯oated on 0.5 ml RPMI medium containing 10% FCS (low endotoxin; Seralab, Kidlington, UK), 2 mM L-glutamine, 200 U/ml penicillin and 100 mg/ml streptomycin (Sigma; RPMI/10) in 24-well hydrophobic culture plates (Greiner Labortechnik, Frickenhausen, Germany). Pinnae were cultured in the absence of any added parasite antigen for 18 h at 37°C, 5% CO 2 . The culture supernatant was then collected, pooled from the two faces for each pinna and stored at ±20°C for subsequent cytokine analysis. The cell population which had detached from the dermis was collected and resuspended in phenotyping buffer (PBS + 0.01% CaCl 2 , 0.01% MgCl 2 and 0.1% BSA) prior to labelling and analysis by¯ow cytometry. For intracellular staining of IL-12p40, cells were cultured as above, but in the presence of 1 mg/ml GolgiPlug (BD PharMingen, Oxford, UK) for 12 h to block cytokine secretion.
The sdLN were removed and disrupted to produce a singlecell suspension (12, 14) . For analysis by¯ow cytometry, sdLN cells were resuspended in phenotyping buffer as above. For in vitro culture, cells were resuspended in RPMI/10 and cultured in 96-well¯at-bottomed plates at a concentration of 4 Q 10 6 /ml in the presence, or absence, of 50 mg/ml soluble larval antigen preparation (SSP) (24) for 72 h at 37°C, 5% CO 2 . Culture supernatants were removed and stored at ±20°C. For the detection of intracellular IFN-g, sdLN cells were cultured in the presence of 1 mg/ml plate-bound aCD3 antibody (BD PharMingen) for 72 h and then for 6 h in the presence of 1 mg/ ml GolgiPlug (BD PharMingen). Proliferation of sdLN cells following 4 days in vitro culture in the presence of SSP was determined following the addition of 0.5 mCi/well [ 3 H]thymidine (Amersham Biosciences, Little Chalfont, UK) during the last 18 h. Cells were then harvested and the incorporation of isotope into cellular DNA determined by scintillation counting (TopCount; Packard, Pangbourne, UK).
Cytokine and ELISAs
Speci®c cytokines released into the culture media from split pinnae and from sdLN cell suspensions were quanti®ed using double-antibody ELISAs as detailed previously (4, 12) . The lower levels of detection in these ELISAs were 20 pg/ml for IL-12p40, IL-6 and IL-4, 25 pg/ml for IFN-g, IL-1b and IL-10, and 100 pg/ml IL-18. All supernatants were tested neat. Data comparisons were tested for signi®cance by using Student's ttest. Arithmetic means are shown T SEM. All experiments were repeated between 2 and 4 times.
Flow cytometric analysis
Single-cell suspensions of dermal exudate and sdLN cells were labelled with anti-mouse mAb prior to analysis by twocolour¯ow cytometry (Coulter XL; Coulter, Luton, UK). Brie¯y, 50 ml aliquots of up to 5 Q 10 5 cells were blocked with 0.5 mg anti-CD16/CD32 (BD PharMingen) and incubated in optimal dilutions of mAb for 30 min on ice. Antibodies were as follows: MHC class II, anti-Ia b,d (M5/114.15.2; BD PharMingen), CD4 (L3/T4; Caltag), CD25 (PC61 5.3; Caltag), CD28 (37.51.1; Caltag), CD40 (3/23; BD PharMingen), CD86 (RMMP-2; Caltag), CD152 (UC10-4F10-11; BD PharMingen) and CD154 (39H5; Serotec). Antibodies were either directly labelled with¯uorochromes (FITC or phycoerythrin) or biotin, in which case streptavidin±Quantum Red (Sigma) was used as a detection probe. Irrelevant isotype-matched antibodies from the relevant supplier were used as controls throughout. For intracellular staining of CD152, IL-12p40 and IFN-g, cells were treated with Cyto®x/Cytoperm (BD PharMingen) prior to and during incubation steps. Anti-cytokine mAb were phycoerythrin-labelled anti-IFN-g (XMG1.2; Caltag) or anti-IL12p40 mAb (C15.6; BD PharMingen), or rat IgG1 isotype control.
Results
In¯ammation of the skin is greater in the absence of IL-10
After vaccination, in¯ammation of the exposure site as judged by pinnae thickness was signi®cantly increased in all three groups of mice by day 2 (all P < 0.05) compared to their naive cohorts, which were all very similar in size (Fig. 1A) . In wildtype mice, the peak of in¯ammation was reached by day 4, after which in¯ammation declined to near naive levels by day 14. A similar pro®le was observed for IL-12p40 ±/± mice which were also signi®cantly less in¯amed than wild-type mice on days 2 and 4 (P < 0.05 and P < 0.01 respectively). In contrast, in¯ammation of pinnae from vaccinated IL-10 ±/± mice continued to increase from day 2 out to day 14. Indeed, pinnae from these mice were thicker than wild-type cohorts at each time point, particularly on days 8 and 14 (P < 0.001). Pinnae from vaccinated IL-10 ±/± mice were also always greater than in IL-12p40 ±/± mice. On day 14, in¯ammation of pinnae from IL-10 ±/± mice was 47 and 67% greater than in wild-type and IL12p40 ±/± mice respectively.
The pro®le of dermal in¯ammation in the different groups judged by pinnae thickness was also observed by histological examination (Fig. 1B) . Although sample preparation leads to shrinkage, it can be seen that the pinnae sections of IL-10 ±/± mice are still substantially thicker than wild-type or IL-12p40 ±/± mice at day 14. In all groups of mice there is evidence of a substantial cellular in¯ux (not edema) into the dermis compared to naive mice (Fig. 1B) , but the cellular in®ltrate in IL-10 ±/± mice was by far the most intense, resulting in a much thicker dermis. Detailed immunohistochemical analysis revealed that the cellular in¯ux was comprised of granulocytes (Gr-1 + ), neutrophils (7/4 + ), macrophages (CD11b + and F4/ 80 + ) and DC (CD11c + ) (Kumkate et al., manuscript in preparation).
Patterns of cytokine produced by skin biopsies are deregulated in IL-12p40 ±/± and IL-10 ±/± mice
The cytokine pro®le in IL-12p40 ±/± and IL-10 ±/± mice after vaccination was compared in order to seek an explanation for the changes seen in the pro®les of dermal in¯ammation and cellularity. As expected, IL-12p40 was not detectable in the supernatants of in vitro cultured pinnae biopsies obtained from IL-12p40 ±/± vaccinated mice, although high levels were produced by pinnae from wild-type mice, and these were maintained at days 2, 4, 8 and 14 p.v. (Fig. 2A) . IL-12p40 was also produced in abundance by the pinnae from IL-10 ±/± mice; the levels were signi®cantly greater than in wild-type mice at all times (P < 0.01±0.001) and were up to 2-fold greater on day 14. IL-10 was produced by pinnae from wild-type mice at all time points, albeit at slightly lower levels on days 8 and 14 (Fig. 2B) . However, production of this cytokine was much greater in IL-12p40 ±/± mice on days 4 onwards (P < 0.001), reaching a plateau between days 8 and 14, when >9-fold more IL-10 was produced by the pinnae of IL-12p40 ±/± compared to wild-type mice. The substantial changes in the quantities of IL-12p40 and IL-10 secreted by the pinnae of IL-10 ±/± and IL-12p40 ±/± mice respectively were not mirrored in the pattern of IL-18 production (Fig. 2C) . Indeed, although there was a 2-fold increase in the amount of IL-18 detected by day 2 p.v., there was no difference between the three groups of mice. A further increase in IL-18 was detected by day 4 p.v. and although less was produced by the samples from IL-10 ±/± mice, this was not signi®cant (P > 0.05). The production of IL-1b by pinnae from both wild-type and IL-12p40 ±/± mice peaked on day 2 p.v. and declined to, or below, naive levels thereafter (Fig. 2D) .
While a similar pattern of IL-1b production was observed in IL-10 ±/± mice, the levels were greater than in the other two groups of mice. Levels of IL-1b, IL-12p40, IL-18 and IL-10 production in naive mice for each group of mice were not markedly different, and for clarity the mean values are shown as a single horizontal line. We also detected elevated IL-6, IL-4 and IFN-g in the culture supernatants of vaccinated pinnae (data not shown). No differences were observed between the three groups of mice for the production of IL-6 and IL-4, and although peak levels of IFN-g were 3-fold greater for IL-10 ±/± mice (P < 0.01), these were much lower (maximum 300 pg/ml) than those seen for sdLN cultures (cf. Fig. 7 ).
In the absence of IL-12, the expression of MHC II is markedly reduced.
In order to establish what effect the production of IL-12 in the pinna had on the ability of accessory cells to act as APC, we examined the expression of MHC II in cryosections of the pinnae. By day 4 p.v., MHC II + cells were abundant in wildtype mice, particularly within foci of cellular in®ltrate in the dermis which formed in response to migrating larvae (Fig. 3B) . The number of MHC II + cells in the dermis of IL-10 ±/± mice was greater than in wild-type mice, but it is dif®cult to accurately quantify any increase (Fig. 3C ) and our results could represent an increase in the level of MHC II antigen expression per cell. However, MHC II + cells were clearly much less abundant in IL-12p40 ±/± mice (Fig. 3D) .
To be effective as APC, the MHC II + cells need to traf®c to the sdLN in order to prime CD4 + cells located in the paracortical areas. In this context, a large number of cells spontaneously emigrate from pinnae biopsies cultured in vitro peaking on day 4 (12). The number of emigrant cells was 15±25% greater for IL-10 ±/± mice (data not shown) and a signi®cant proportion were found to be MHC II + (Fig. 4A) . The percentage positive for MHC II was signi®cantly greater in IL-10 ±/± mice, but was lower in IL-12p40 ±/± mice relative to the number in wild-type mice (P < 0.05; Fig. 4A ). This pattern was also observed when analysis was restricted to those cells expressing high levels of MHC II. The dermal exudate cells from IL-10 ±/± mice also expressed signi®cantly higher levels of CD86 than either wild-type or IL-12p40 ±/± mice (P < 0.001). It was also evident that the proportion of IL-12p40 + cells in the dermal exudate was greater in IL-10 ±/± mice (7.17%) compared to wild-type mice (6.05%) (Fig. 4B) . Moreover, >90% of all IL-12p40 + cells in the dermal exudate of IL-10 ±/± and wild-type mice were also MHC II + .
The absence of IL-10 leads to increased cellularity and proliferation in the sdLN
In naive mice of each strain, there was little difference between the total numbers of cells and the proportions of CD4 + and B220 + cells (Fig. 5A±C) . Exposure of mice to RA larvae caused an increase in the sdLN cell number, particularly of B220 + cells which, as noted previously (25) , results from an in¯ux of naive B cells and effectively diluting the CD4 + cell population. Nevertheless, the absence of IL-10 caused a greater increase in the overall cellularity, most noticeably on day 14 when there was a 66% increase in the cell number of the sdLN from IL-10 ±/± compared to wild-type mice (P < 0.001; Fig. 5A ). At the same time the sdLN of IL-12p40 ±/± mice had signi®cantly fewer cells (P < 0.05). However, IL-10 ±/± mice had a signi®cantly lower proportion of CD4 + cells on both days 4 and 14 p.v. than either of the other two groups (Fig. 5B) . Indeed, on day 14, IL-12p40 ±/± mice had a signi®cantly higher proportion of CD4 + cells compared to wild-type mice. In contrast, the proportion of B220 + lymphocytes in the sdLN was signi®cantly greater in IL-10 ±/± mice than the other two groups (Fig. 5C) . Analysis of sdLN cells cultured in vitro with soluble schistosome antigen revealed that proliferation of cells from IL-12p40 ±/± mice was lower than in wild-type mice on both days 4 and 14 (P < 0.01; Fig. 5D ). On the other hand, the proliferation of sdLN cells for IL-10 ±/± mice was greater than for wild-type mice on both days 4 and 14, although the increase at the earlier time point was not signi®cant (Fig. 5E ).
Markers of activation and co-stimulation are elevated in the absence of IL-10
Since levels of lymphocyte proliferation were greater in the absence of IL-10, changes in the expression of various markers of activation and co-stimulation following vaccination were investigated. In nearly all cases, differences in the levels of expression between different groups were not evident on day 4, but were readily observed on day 14. CD25 expression correlated with the pattern of lymphocyte proliferation on day 14 with elevated levels on CD4 + cells from IL-10 ±/± mice, but reduced levels were recorded on cells from IL-12p40 ±/± mice (P < 0.01; Fig. 6A ). Increased co-stimulatory molecule expression on CD4 + cells was only evident for CD28 and CD152 at day 14, with no change in CD154 (Fig. 6B±D ). There were no signi®cant changes in APC expression of CD86 (Fig. 6E) , but there were small signi®cant increases in the levels of both CD40 and MHC II hi in IL-10 ±/± mice (Fig. 6F±G) . CD40 expression was also lower in IL-12p40 ±/± (P < 0.05) compared to wild-type mice, but MHC II expression was not signi®cantly different. In all cases, statistical difference shown in Fig. 6 is for cytokine-de®cient mice compared to wild-type cohorts. However, in most cases equivalent, or higher, levels of signi®cance are obtained when comparing the data collected for IL-10 ±/± versus IL-12p40 ±/± mice (data not shown). No signi®cant differences were recorded between the three groups of naive mice in their expression of the various co-factors described above.
The pro®le of cytokines produced by sdLN cells from IL12p40 ±/± and IL-10 ±/± reveals polarization towards T h 2-and T h 1-type responses respectively Cells from the sdLN of wild-type mice cultured in vitro in the absence of added antigen were ef®cient producers of IL-12p40 at both days 4 and 14 p.v. (Fig. 7A) . In this situation, detection of IL-12 represents its production in vivo in response to antigen from the RA larvae. As expected, detection of this molecule in IL-12p40 ±/± mice was at or below the lower level of detection for this ELISA. In contrast, the production of IL12p40 in IL-10 ±/± mice was greatly elevated above that in wildtype mice, although in this experiment signi®cance was achieved on day 4 only (P < 0.01). Cells from wild-type mice secreted sustained quantities of antigen-driven IFN-g on days 4 and 14 p.v., but the amount produced by cells from IL12p40 ±/± mice was negligible (Fig. 7B) . However, the secretion of IFN-g was much greater in IL-10 ±/± than wild-type and IL12p40 ±/± mice at both days 4 and 14 (P < 0.01). Although cells from wild-type mice produced only small quantities of IL-4, cells from IL-12p40 ±/± mice produced abundant IL-4, particularly at day 4 (P < 0.001; Fig. 7C ). In contrast, we were unable to detect the secretion of IL-4 from the cells of IL-10 ±/± mice. Antigen-driven IL-10 production was greater in IL-12p40 ±/± compared to wild-type mice and the levels were higher at day 4 than 14. No IFN-g, IL-4 or IL-10 was detected in the absence of added antigen at either time point and none were detected in cultures of sdLN cells from naive mice. Further analysis of IFN-g production by intracellular cytokine staining shows that on day 4 there are >80% more CD4 + IFN-g + cells in the sdLN of IL-10 ±/± than wild-type mice, but there were nearly 60% fewer CD4 + IFN-g + cells in IL-12p40 ±/± mice (Fig. 7E) . Moreover, the mean intensity of¯uorescence for IFN-g staining was 30% greater (2.44 T 0.32) for CD4 + cells on day 4 p.v. from IL-10 ±/± mice compared to wild-type mice (1.86 T 0.24). By day 14, a similar pro®le was observed with 70% more CD4 + IFN-g + cells in the sdLN of IL-10 ±/± than wild-type mice, although the overall number of CD4 + IFN-g + cells was lower at day 14 than at day 4 in all groups of mice. Together these results con®rm that the IL-10 ±/± mice have a more T h 1-biased acquired immune response, whilst IL-12p40 ±/± mice are more T h 2 biased.
Discussion
The role of IL-10 is a key agent in the control of excessive in¯ammation and immune-related immunopathologies. In this paper, we show that the early production of IL-10 in the skin of mice exposed to the RA schistosome vaccine has an important role in controlling a series of IL-12-mediated immune events that in turn govern the scale of the ensuing T h 1-type protective immune response. The initial in¯ammatory response in the skin is characterized by an increase in tissue thickness caused by an in¯ux of polymorphonuclear and mononuclear cells [(4) and Kumkate, manuscript in preparation], and the rapid release of pro-in¯ammatory and chemotactic cytokines including IL-1b IL-6, IL-12, MIP-1a and MIP-1b [here and (4)]. However, we also recorded the production of IL-10 in dermal tissues, which is known to have anti-in¯ammatory effects, particularly in the regulation of IL-12-mediated immune responsiveness (21) . This raises the question as to how IL-12 and IL-10 interact during stimulation of the innate response, and how this affects the acquired immune response. In¯ammation of skin exposed to the RA vaccine was signi®cantly elevated in the absence of IL-10, but decreased in the absence of IL-12. Histological analysis of pinnae demonstrated that the maintenance of dermal in¯ammation was largely due to the presence of cellular in®ltrates (rather than simply edema), while in wild-type and IL-12p40 ±/± mice the foci largely resolved by day 14 and resembled the pinnae of naive mice despite the predicted persistence of up to 25% of the RA larvae (15) . The resolution of dermal in¯ammation (except in IL-10 ±/± mice) in the face of a substantial parasite antigen load strongly implicates an immunoregulatory role for IL-10. In fact, endogenous IL-10, but not IL-4, is a key factor in the control of dermal in¯ammation due to croton oil-induced contact sensitivity (26) . After exposure to normal larvae, the secretion of IL-10 in the skin in response to parasite-and/or host-derived prostaglandin E 2 may explain the ability of normal larvae to modulate dermal in¯ammation (27) . Prostaglandin E 2 is a potent stimulant of IL-10 production (28, 29) operating via a cyclooxygenase 2-dependent pathway (30) . However, our demonstration that RA larvae also induce IL-10 contradicts previous reports showing that RA larvae do not elicit IL-10 in the skin (27, 31) . Differences in protocol may explain our contrasting results, but we believe that RA larvae stimulate IL-10 production in the skin via a pathway which is similar, if not identical, to that proposed for normal larvae.
IL-10 appears to regulate the effects of IL-12 and IL-1b since in its absence elevated levels of both cytokines were evident compared to wild-type cohorts. In this context, IL-10 is a potent inhibitor of IL-12 transcription (32) and interferes with IL-12 production by DC (33) . As a corollary, we observed increased levels of IL-10 in IL-12p40 ±/± mice, demonstrating that IL-12 ordinarily restrains the production of IL-10. Such divergent patterns of cytokine production were not evident for all molecules because no differences in IL-18 (or IL-6) production between the groups were seen at any time point. Therefore, although IL-18 can act in synergy with IL-12 (34), it does not appear to be an important factor in this model. On the other hand, since IL-12 is also a potent inducer of IFN-g (18), it was not surprising that elevated levels of IFN-g were detected for IL-10 ±/± skin biopsies. However, only very limited quantities were detected (cf. levels in sdLN). Moreover, levels of IL-10 and IL-12 were not substantially affected by the absence of IFN-g signalling in vaccinated IFN-gR ±/± mice (Hogg, unpublished observations), suggesting that IFN-g does not have an important regulatory effect upon these cytokines in the skin.
A major event in the skin following vaccination is the uptake of parasite antigen by local APC prior their migration to the sdLN where they can present antigen. In this context, IL-10 down-regulates a number of essential factors including the expression of MHC II and B7 molecules, (35, 36) , cytokine production (33) , and the emigration of MHC II + cells from sites of dermal in¯ammation (37) . Conversely, IL-12 causes the upregulation of pro-in¯ammatory cytokines and MHC II (38) , and synergizes with B7/CD28 to promote CD4 + cell proliferation and cytokine production (39) . Therefore, the presence of IL-10 and/or IL-12 should have important effects upon T cell priming through their actions on APC or antigen presentation by APC. Our data support this contention in as much that in the absence of IL-12p40, there was a decrease in the number of dermal MHC II + cells, while the absence of IL-10 leads to an increase. Increased CD86 expression by dermal exudate cells from IL-10 ±/± mice is also consistent with the IL-10-mediated regulation of CD86 on dermal DC from psoriatic skin (40) .
Although more cells were observed in the dermal exudate of IL-10 ±/± mice, in agreement with enhanced Langerhans cell migration in the absence of IL-10 (37), this may simply re¯ect the greater numbers in the in¯amed pinnae. Moreover, in another model of schistosome-induced Langerhans cell migration, a role for IL-10 was not found (41) . Nevertheless, our data strongly suggest that abundant IL-12 in the absence of IL-10 leads to an environment more conducive to the development of antigen-primed MHC II + APC in the skin which should have clear effects upon acquired immune events and the sdLN. The absence of IL-10 resulted in greater numbers of sdLN cells on day 14, whilst antigen-driven cell proliferation was greater, supportive of ®ndings by Hoffmann et al. (10) . However, CD4 + cells were less abundant and B cells more frequent in IL-10 ±/± mice, suggesting that the increased sdLN cell number in these mice may be caused by a preferential expansion of B cells. In turn, this would provide conditions for increased antibody production that is a feature of IL-10 ±/± mice (10).
The greater levels of cell proliferation in the absence of IL-10 were re¯ected in slightly enhanced expression of various cofactors on accessory and CD4 + cells on day 14. Indeed, expression of CD25 is indicative of recent immune activation, while CD152 at low levels of expression has activation properties, although both have been linked to a`regulatory' phenotype (42) . Given the large changes in cytokine production detected in the sdLN, it is perhaps surprising that changes in the levels of activation markers and co-stimulatory molecules were not greater. Nevertheless, the general pattern supports the notion that IL-10 down-regulates the ef®ciency of immune priming in the sdLN.
Finally, the changes noted above in the absence of IL-10, or IL-12p40, have major effects upon the cytokine pro®le by cells from the sdLN. Cells spontaneously secreted more IL-12p40 in the absence of IL-10 than cells from their wild-type cohorts and translated to a biased pattern of cytokine production in antigen-driven cultures. In this respect, DC matured in the presence of IL-10 have an impaired capacity to drive T h 1-type responses caused by their poor synthesis of IL-12 (33) . Not only were more CD4 + IFN-g + cells detected in the sdLN in the absence of IL-10, but the amount of IFN-g per cell was increased as judged by the intensity of IFN-g staining.
Although analysis of the immune effector response was not an objective of our study, the data presented here are consistent with the view that, following exposure of C57BL/6 mice to a single dose of RA larvae, IL-12-mediated T h 1-type immune effector mechanisms dominate and are responsible for vaccine-induced protection. It is well documented that in the absence of IL-12, protective immune responses are substantially reduced, concurrent with an elevated T h 2-type immune environment (10, 20) , whilst the absence of IL-10 leads to the induction of very high levels of immunity (10) . However, in the absence of strong T h 1-polarizing cytokines (10, 20) , following multiple vaccination (10, 43) or in other strains of mice (12) , antibody-mediated parasite clearance has an additional protective role (11) .
In conclusion, we show that IL-10 plays an important role regulating the very early events of immune stimulation both in the skin and sdLN after exposure to RA larvae. The inhibitory functions of IL-10 appear to operate against accessory cells (e.g. DC), but it remains a challenge for us to establish the cellular origin of IL-10 in the skin. In this respect, IL-10 derived from dermal CD4 + cells is an important factor in the persistence of Leishmania major (44) . In the absence of IL-10, IL-12 from skin-derived DC and/or macrophages (4) is enhanced leading to increased MHC II and co-stimulatory molecule expression, and ®nally resulting in strong T h 1 cell polarization. In contrast, the absence of IL-12p40 leads to an abundance of IL-10 which down-regulates MHC II and ultimately affects the ef®ciency of T cell activity in the sdLN. This study highlights the role of early IL-10 as a brake on IL-12-mediated immune priming and suggests that approaches to control its in¯uence, whilst at the same time limiting in¯ammation, are important issues to address during the design of anti-parasite vaccines.
